Clinical Trial Update: Intramuscular Transplantation of Muscle Derived Stem Cell and Adipose Derived Mesenchymal Stem Cells in Patients With Facioscapulohumeral Dystrophy (FSHD) [Phase 1]

View source ↗

Summary

Phase 1 clinical trial evaluating intramuscular transplantation of muscle-derived stem cells and adipose-derived mesenchymal stem cells in patients with faciosc…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Facioscapulohumeral Muscular Dystrophy

Drugs mentioned

• Adipose-derived mesenchymal stem cells
• Muscle-derived stem cells

Snippet

Sponsor: Royan Institute | Conditions: Dystrophy | Phase 1 | Status: UNKNOWN